Deutsch English Français

Contact

EP3749645

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3749645

EP3749645 - 3-(BENZYLAMINO)-4-(CYCLOHEXYLAMINO)-N-(2-(PIPERAZIN-1-YL)ETHYL)BENZENESULFONAMIDE DERIVATIVES AND RELATED FERROSTATIN-1 ANALOGUES AS CELL DEATH INHIBITORS FOR TREATING E.G. STROKE [Right-click to bookmark this link]
Former [2020/51]	3-(BENZYLAMINO)-4-(CYCLOHEXYLAMINO)-N-(2-(PIPERAZIN-1-YL)ETHYL)BENZENESULFONAMIDE DERIVATIVES AND RELATED FERROSTATIN-1 ANALOGUES AS CELL DEATH INHIBITORS FOR TREATING E.G. STROKE
	[2024/04]
Status	Examination is in progress Status updated on 04.07.2024 Database last updated on 05.08.2024
Former	Grant of patent is intended Status updated on 24.01.2024
Former	Examination is in progress Status updated on 01.10.2021
Former	Request for examination was made Status updated on 13.11.2020
Former	The international publication has been made Status updated on 17.08.2019
Former	unknown Status updated on 16.02.2019
Most recent event Tooltip	24.07.2024	New entry: Communication of intention to grant a patent
	24.07.2024	Deletion - Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
Applicant(s)	For all designated states VIB VZW Suzanne Tassierstraat 1 9052 Gent / BE
	For all designated states Universiteit Antwerpen Prinsstraat 12 2000 Antwerpen / BE
	For all designated states Universiteit Gent Sint-Pietersnieuwstraat 25 9000 Gent / BE
	[2024/07]
Former [2021/03]	For all designated states VIB VZW Rijvisschestraat 120 9052 Gent / BE
	For all designated states Universiteit Antwerpen Prinsstraat 12 2000 Antwerpen / BE
	For all designated states Universiteit Gent Sint-Pietersnieuwstraat 25 9000 Gent / BE
Former [2020/51]	For all designated states VIB vzw Rijvisschestraat 120 9052 Gent / BE
	For all designated states Universiteit Antwerpen Prinsstraat 12 2000 Antwerpen / BE
	For all designated states Universiteit Gent Sint-Pietersnieuwstraat 25 9000 Gent / BE
Inventor(s)	01 / VANDENABEELE, Peter Nijverheidstraat 18 9040 Sint-Amandsberg / BE
	02 / VANDEN BERGHE, Tom Stuurstraat 124 9120 Haasdonk / BE
	03 / AUGUSTYNS, Koen Heike 2 2322 Hoogstraten / BE
	04 / HOFMANS, Sam Dirkputstraat 81 Bus 2.2 2850 Boom / BE
	05 / VAN DER VEKEN, Pieter Goorboslei 47 2560 Sint-Katelijne-Waver / BE
	06 / DEVISSCHER, Lars Dokter Paul Janssenlaan 5, bus 3 2300 Turnhout / BE
	[2020/51]
Representative(s)	De Clercq & Partners Edgard Gevaertdreef 10a 9830 Sint-Martens-Latem / BE
	[2020/51]
Application number, filing date	19703097.6	05.02.2019
	[2020/51]
	WO2019EP52751
Priority number, date	GB20180001943	07.02.2018 Original published format: GB 201801943
	[2020/51]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2019154795
	Date:	15.08.2019
	Language:	EN
	[2019/33]
	Type:	A1 Application with search report
	No.:	EP3749645
	Date:	16.12.2020
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.08.2019 takes the place of the publication of the European patent application.
	[2020/51]
Search report(s)	International search report - published on:	EP	15.08.2019
Classification	IPC:	C07C311/38, C07D295/14, C07D295/12, C07D213/38, A61K31/18, A61K31/495, A61K31/5375, A61P9/10, A61P3/10, A61P37/06, A61P25/28, A61P25/16, // A61K31/185, A61P1/16, A61P25/14, C07C311/17, C07C311/39, C07C311/40, C07C311/41	[2024/04]
	CPC:	C07D295/14 (EP); C07C311/39 (EP,US); A61K31/185 (EP); A61P1/16 (EP); A61P25/14 (EP); A61P25/16 (EP); (+) A61P25/28 (EP); A61P3/10 (EP); A61P37/06 (EP); A61P9/10 (EP); C07C311/38 (EP); C07C311/40 (EP); C07C311/41 (EP); C07D213/38 (EP); C07D221/00 (US); C07D227/02 (US); C07D227/04 (US); C07D241/04 (US); C07D295/027 (US); C07D295/12 (EP); C07C311/17 (EP) (-)
	Former IPC [2020/51]	C07C311/38, C07D295/14, C07D295/12, C07D213/38, A61K31/18, A61K31/495, A61K31/5375, A61P9/10, A61P3/10, A61P37/06, A61P25/28, A61P25/16
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/51]
Title	German:	3-(BENZYLAMINO)-4-(CYCLOHEXYLAMINO)-N-(2-(PIPERAZIN-1-YL)ETHYL)BENZENSULFONAMID-DERIVATE UND ÄHNLICHE FERROSTATIN-1 ANALOGE ALS ZELLTOD-INHIBITOREN ZUR BEHANDLUNG VON Z.B. SCHLAGANFALL	[2024/32]
	English:	3-(BENZYLAMINO)-4-(CYCLOHEXYLAMINO)-N-(2-(PIPERAZIN-1-YL)ETHYL)BENZENESULFONAMIDE DERIVATIVES AND RELATED FERROSTATIN-1 ANALOGUES AS CELL DEATH INHIBITORS FOR TREATING E.G. STROKE	[2024/32]
	French:	DÉRIVÉS DE 3-(BENZYLAMINO)-4-(CYCLOHÉXYLAMINO)-N-(2-(PIPÉRAZIN-1-YL)ÉTHYL)BENZENESULFONAMIDE ET ANALOGUES DE FERROSTATIN-1 SIMILAIRES EN TANT QU'INHIBITEURS DE LA MORT CELLULAIRE POUR LE TRAITEMENT PAR EX. D'UN ACCIDENT VASCULAIRE CÉRÉBRAL	[2024/32]
	Former [2020/51]	3-(BENZYLAMINO)-4-(CYCLOHEXYLAMINO)-N-(2-PIPERAZIN-1-YL) ETHYL) BENZOLSULFONAMIDDERIVATE UND VERWANDTE FERROSTATIN-1-ANALOGA ALS ZELLTODINHIBITOREN ZUR BEHANDLUNG VON Z.B. SCHLAGANFALL
	Former [2020/51]	3-(BENZYLAMINO)-4-(CYCLOHEXYLAMINO)-N-(2-(PIPERAZIN-1-YL)ETHYL)BENZENESULFONAMIDE DERIVATIVES AND RELATED FERROSTATIN-1 ANALOGUES AS CELL DEATH INHIBITORS FOR TREATING E.G. STROKE
	Former [2020/51]	DÉRIVÉS DE 3-(BENZYLAMINO)-4-(CYCLOHEXYLAMINO)-N-(2-(PIPÉRAZIN-1-YL)ÉTHYL)BENZÈNESULFONAMIDE ET ANALOGUES DE FERROSTATINE-1 ASSOCIÉS EN TANT QU'INHIBITEURS DE MORT CELLULAIRE POUR LE TRAITEMENT, PAR EXEMPLE, D'UN ACCIDENT VASCULAIRE CÉRÉBRAL
Entry into regional phase	07.09.2020	National basic fee paid
	07.09.2020	Designation fee(s) paid
	07.09.2020	Examination fee paid
Examination procedure	deleted	Communication of intention to grant the patent
	07.09.2020	Amendment by applicant (claims and/or description)
	07.09.2020	Examination requested [2020/51]
	07.09.2020	Date on which the examining division has become responsible
	01.10.2021	Despatch of a communication from the examining division (Time limit: M04)
	27.01.2022	Reply to a communication from the examining division
	10.08.2022	Despatch of a communication from the examining division (Time limit: M04)
	08.12.2022	Reply to a communication from the examining division
	28.03.2023	Despatch of a communication from the examining division (Time limit: M06)
	27.09.2023	Reply to a communication from the examining division
	25.01.2024	Communication of intention to grant the patent
	24.05.2024	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
Fees paid	Renewal fee
	22.02.2021	Renewal fee patent year 03
	22.02.2022	Renewal fee patent year 04
	23.02.2023	Renewal fee patent year 05
	26.02.2024	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[AD]WO2016075330 (VIB VZW [BE], et al);

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p